Position in BCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$864,810
-$407,032 QoQ
Shares Held
86,481
-35.3% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#130
of 316 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Derivatives in BCRX
reported options exposure · as of Dec 31, 2024CallValue
$0
CallShares
0
PutValue
$75,200
PutShares
10,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $487,957,812 across 61 Drug Manufacturers - Specialty & Generic names. BCRX ranks #23 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
2,302,737 | $165,474,680 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
324,807 | $54,742,970 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,343,554 | $45,519,608 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
72,010 | $39,017,177 | |
| 5 | VTRS |
Viatris Inc
|
2,437,004 | $38,699,622 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
907,024 | $37,215,193 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
861,006 | $29,851,076 | |
| 8 | ALKS |
Alkermes plc.
|
219,935 | $11,524,592 |
All Filings in BCRX
Export CSV
35 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $864,810 | 86,481 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,271,842 | 133,597 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,665,661 | 726,367 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,937,139 | 782,232 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $7,204,842 | 804,112 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $3,019,500 | 402,600 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $3,491,129 | 464,246 | Shares | Sole | 2026-03-19 | |
| 2024-12-31 | $75,200 | 10,000 | Put | Sole | 2026-03-19 | |
| 2024-09-30 | $76,000 | 10,000 | Put | Sole | 2026-03-31 | |
| 2024-09-30 | $3,622,706 | 476,672 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $1,400,300 | 226,586 | Shares | Sole | 2026-03-23 | |
| 2024-06-30 | $61,800 | 10,000 | Call | Sole | 2026-03-23 | |
| 2024-03-31 | $1,403,390 | 276,258 | Shares | Sole | 2026-03-24 | |
| 2024-03-31 | $101,600 | 20,000 | Put | Sole | 2026-03-24 | |
| 2023-12-31 | $359,400 | 60,000 | Put | Sole | 2026-03-24 | |
| 2023-12-31 | $4,220,127 | 704,529 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $3,875,082 | 547,328 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $3,870,162 | 549,739 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $5,864,462 | 703,173 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $5,561,967 | 484,492 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $5,185,101 | 411,516 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $919,221 | 86,883 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,989,036 | 122,327 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,026,668 | 218,532 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,134,022 | 78,916 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $543,864 | 34,400 | Call | Sole | 2021-08-13 | |
| 2021-06-30 | $1,299,091 | 82,169 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,392,929 | 235,293 | Shares | Sole | 2021-05-13 | |
| 2021-03-31 | $522,738 | 51,400 | Call | Sole | 2021-05-13 | |
| 2020-12-31 | $730,322 | 98,030 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $989,704 | 287,705 | Shares | Sole | 2020-11-12 | |
| 2020-09-30 | $235,296 | 68,400 | Call | Sole | 2020-11-12 | |
| 2020-06-30 | $1,778,863 | 373,711 | Shares | Sole | 2020-08-12 | |
| 2020-06-30 | $723,996 | 152,100 | Call | Sole | 2020-08-12 | |
| 2020-03-31 | $2,297,692 | 1,148,846 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||